eMind

Successfully demonstrated ability to predict depression by analyzing sleep and behavioral data from smartphones in a PoC study involving 160 participants over one month. The technology has been patented as an information processing system for determining evaluation data on the severity of mental illness. The company collaborates with medical institutions and offers enterprise services focused on organizational revitalization through individual well-being support. No drug or biologic clinical results reported. Focused on early detection/intervention rather than treatment. Commercialization status not specified but appears active in B2B partnerships. Offers "eMind for Business" service targeting corporate clients.